Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | GLO1 | Q04760 | 1/20 | 0.41 |
| ▸ | FAAH | O00519 | 2/20 | 0.40 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.39 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.38 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | MEN1 | O00255 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.34 |
| ▸ | MGAM | O43451 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | SI | P14410 | 1/20 | 0.34 |
| ▸ | MGAM2 | Q2M2H8 | 1/20 | 0.34 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8206951 | 1.00 | NPSR1 (0.41) | NPSR1GLO1FAAHSOAT1GRIK1 | |
| SCHEMBL27579977 | 0.88 | FAAH (0.45) | NPSR1GLO1FAAHSOAT1GRIK1 | |
| SCHEMBL28356606 | 0.85 | FAAH (0.54) | NPSR1FAAHSOAT1LMNAHSD17B10 | |
| SCHEMBL5213142 | 0.85 | FAAH (0.54) | NPSR1FAAHSOAT1LMNAHSD17B10 | |
| SCHEMBL5213149 | 0.85 | FAAH (0.54) | NPSR1FAAHSOAT1LMNAHSD17B10 | |
| SCHEMBL11852829 | 0.85 | FAAH (0.54) | NPSR1FAAHSOAT1LMNAHSD17B10 | |
| SCHEMBL4627059 | 0.85 | GRIK1 (0.41) | GRIK1GRIK2ALDH1A1 | |
| SCHEMBL4627053 | 0.85 | GRIK1 (0.41) | GRIK1GRIK2ALDH1A1 | |
| SCHEMBL5964062 | 0.84 | ALDH1A1 (0.43) | NPSR1GLO1FAAHGRIK1GRIK2 | |
| Ammonia Solution, Strong SCHEMBL27608605 | 0.84 | HCAR2 (0.37) | GRIK1GRIK2ALDH1A1SMN1; SMN2LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117825528-A | Detection method of ethyl carboxylate derivative and application thereof | 中山奕安泰医药科技有限公司 | 2024-04-05 | — | — | CN | claimed |
| CN-115598239-A | Method for detecting related substances in oseltamivir phosphate starting material | 植恩生物技术股份有限公司（CN） | 2023-01-13 | — | — | CN | claimed |
| CN-115417783-A | Method for synthesizing oseltamivir enantiomer | 苏州匠化生物科技有限公司 | 2022-12-02 | — | — | CN | claimed |
| CN-111499536-B | Preparation method of oseltamivir | 湖南欧亚药业有限公司 | 2022-10-18 | — | — | CN | claimed |
| CN-114424365-A | Cathode for secondary battery and cathode slurry | 广东省皓智科技有限公司 | 2022-04-29 | — | — | CN | claimed |
| CN-113024489-A | Preparation method of oseltamivir synthesis process impurity | 上海奥博生物医药技术有限公司 | 2021-06-25 | — | — | CN | claimed |
| CN-111499536-A | Preparation method of oseltamivir | 湖南欧亚药业有限公司 | 2020-08-07 | — | — | CN | claimed |
| CN-122059843-A | Method for synthesizing oseltamivir phosphate | 重庆圣华曦药业股份有限公司 | 2026-05-19 | — | — | CN | disclosed |
| CN-117825528-A | Detection method of ethyl carboxylate derivative and application thereof | 中山奕安泰医药科技有限公司 | 2024-04-05 | — | — | CN | disclosed |
| CN-117571887-A | Method for detecting related substances of oseltamivir phosphate key starting materials | 迪嘉药业集团股份有限公司 | 2024-02-20 | — | — | CN | disclosed |
| CN-116283832-A | Preparation method of oseltamium Wei Gongyi impurity | 中科苏州药物研究院 | 2023-06-23 | — | — | CN | disclosed |
| CN-111153818-B | Method for preparing antiviral drug Tamiflu intermediate tert-butylamine derivative I | 遂成药业股份有限公司 | 2023-03-28 | — | — | CN | disclosed |
| CN-115598239-A | Method for detecting related substances in oseltamivir phosphate starting material | 植恩生物技术股份有限公司（CN） | 2023-01-13 | — | — | CN | disclosed |
| CN-113549033-A | Crystallization method of intermediate 5 of high-purity oseltamivir phosphate | 福建省福抗药业股份有限公司 | 2021-10-26 | — | — | CN | disclosed |
| CN-113024489-A | Preparation method of oseltamivir synthesis process impurity | 上海奥博生物医药技术有限公司 | 2021-06-25 | — | — | CN | disclosed |
| CN-111499536-A | Preparation method of oseltamivir | 湖南欧亚药业有限公司 | 2020-08-07 | — | — | CN | disclosed |
| CN-111499536-A | Preparation method of oseltamivir | 湖南欧亚药业有限公司 | 2020-08-07 | — | — | CN | disclosed |
| CN-111153818-A | Method for preparing antiviral drug Tamiflu intermediate tert-butylamine derivative I | 遂成药业股份有限公司 | 2020-05-15 | — | — | CN | disclosed |
| CN-105585601-A | Anti-aging skin external composition and preparation method thereof | HAYASHIBARA CO | 2016-05-18 | — | — | CN | disclosed |
| EP-1059283-A1 | Process for preparing neuraminidase inhibitor ro-64-0796 | F. HOFFMANN-LA ROCHE AG (CH) | 2000-12-13 | — | — | EP | disclosed |